BioPorto Diagnostics
Overview
BioPorto develops and markets antibodies and antibody-based products, including tests to diagnose human disease, both for the benefit of individual patients and to promote efficiency in the health sector.
The Company’s developments include a test (NGAL) to diagnose and monitor acute kidney damage. BioPorto’s strategy is to develop new methods based on its antibody portfolio that can be patented and achieve a wide use in the diagnosis of various diseases.
BioPorto Diagnostics A/S offers the range of antibodies under the AntibodyShop® brand. Focus areas include:
- Bioactive peptides
- Complement system and collectins
- Cell biology
Home Page: http://www.bioporto.com and http://www.antibodyshop.com
Website:
http://www.bioporto.comCountry of Origin:
DenmarkCoverage:
IndonesiaProduct Range:
- APC-PCI ELISA Kit
- Cell biology
- Coagulation
- Collectins and related products
- Complement
- Cytokines and hormones
- Enzymes
- Gc-globulin (Actin-free) ELISA Kit
- Marker molecules
- MBL Oligomer ELISA Kit
- Microbiology
- Miscellaneous
- NGAL ELISA Kits
- Oncology
- Other blood proteins
- Sera and Antigens
[E-mail Us]